Read more

September 17, 2022
1 min read
Save

Simultaneous bilateral total ankle arthroplasty seen as comparable to staged procedure

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

QUEBEC CITY — Under surgeon expertise in appropriately selected patients, simultaneous bilateral total ankle arthroplasty has comparable outcomes with the staged procedure for patients with bilateral end-stage ankle osteoarthritis.

Amanda N. Fletcher
Amanda N. Fletcher

“Patients with bilateral end-stage ankle arthritis represent a unique population with a higher incidence of primary OA,” Amanda N. Fletcher, MD, MS, said in her presentation at the American Orthopaedic Foot & Ankle Society Annual Meeting. “There have been no previous reports comparing bilateral-stage vs. simultaneous ankle arthroplasty, which was our goal in this study,” she added.

Foot Ankle Injury
Source: Adobe Stock

Fletcher and colleagues at Duke University Medical Center performed a comparative cohort study of 50 patients (mean age of 64.3 years) who underwent primary total ankle arthroplasty (TAA) between 2007 and 2019 and had an average follow-up of 52.2 months. Mean time between surgeries was 17.5 months in patients who underwent staged TAA. According to the abstract, 56% of patients (n = 28) had primary OA.

Overall, no significant differences were found between the cohorts in pain, patient-reported outcome measures or perioperative complications. The simultaneous bilateral cohort had a perioperative complication rate of 22% and a reoperation rate of 6%, while the staged cohort had a perioperative complication rate of 24% and a reoperation rate of 5%. Fletcher noted that reoperation-free survival was 94% at 2 years and 88% at 5 years in the simultaneous cohort, while reoperation-free survival was 96% at 2 years and 90% at 5 years in the staged cohort. Both cohorts had 100% failure-free survival rate at 8 years after surgery.

Fletcher said simultaneous TAA warrants further investigation for the potential benefits of decreased anesthesia events, surgery time, tourniquet time, length of stay, recovery time and overall cost.